LinusBio

North Brunswick, NJ · Founded 2020 · Privately Held (backing)

Developer of a precision exposome medicine platform designed to analyze the molecular impact of environmental exposures on health. LinusBio is based in North Brunswick, NJ and was founded in 2020. Its last reported valuation was $171 million in Jul 2024. It has raised $34.6 million.

Last reported valuation
$171.2M
Oct 2026
Priced at
—
Total raised
$34.6M
Last round
—

Who backs LinusBio?

9 investors
InvestorType
GreatPoint VenturesVenture capital
Bow CapitalVenture capital
Crom Capital ManagementHedge fund
David Bellet Family OfficeFamily office
Divergent Investments—
Gillian Sandler—
Nicole Shanahan—
Sanford Robertson—
YAC Holdings—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

LinusBio investors

9 investors are on record for LinusBio, including GreatPoint Ventures, Bow Capital, Crom Capital Management and David Bellet Family Office.

Free account
More of LinusBio with a free account
  • ·Watch LinusBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like LinusBio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View